microRNA与胃癌关系的研究进展(3)
[11] Xu Y， Sun J， Xu J， miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer. Gastroenterol Res Pract. 2012， 2012：640168.
[12] Tsujiura M， Ichikawa D， Komatsu S， et al.Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer. 2010， 102(7)：1174-1179.
[13] Cai H， Yuan Y， Hao YF， et al. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med Oncol. 2013， 30(1)：452.
[14] Song MY，Pan KF，Su HJ， et al.Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer.PLoS One， 2012， 7( 3) ： e33608.
[15] Jiang Z，Guo J，Xiao B，et al. Increased expression of miRNA -421 in human gastric carcinoma and its clinical association. J Gastroenterol，2010， 45(1)：17-23.
[16] Xia L，Zhang D，Du R，et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer， 2008， 123(2)：372-379.
[17] Jiang J，Zheng X，Xu X， et al. Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/ Oxaliplatin.PLoS One， 2011， 6(8)：e23271.
[18] Brenner B， Hoshen MB， Purim O， et al. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol. 2011， 17(35)：3976-3985.
[19] Konishi H， Ichikawa D， Komatsu S， et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer. 2012， 106(4)：740-747., http://www.100md.com(覃新干)
[12] Tsujiura M， Ichikawa D， Komatsu S， et al.Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer. 2010， 102(7)：1174-1179.
[13] Cai H， Yuan Y， Hao YF， et al. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med Oncol. 2013， 30(1)：452.
[14] Song MY，Pan KF，Su HJ， et al.Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer.PLoS One， 2012， 7( 3) ： e33608.
[15] Jiang Z，Guo J，Xiao B，et al. Increased expression of miRNA -421 in human gastric carcinoma and its clinical association. J Gastroenterol，2010， 45(1)：17-23.
[16] Xia L，Zhang D，Du R，et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer， 2008， 123(2)：372-379.
[17] Jiang J，Zheng X，Xu X， et al. Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/ Oxaliplatin.PLoS One， 2011， 6(8)：e23271.
[18] Brenner B， Hoshen MB， Purim O， et al. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol. 2011， 17(35)：3976-3985.
[19] Konishi H， Ichikawa D， Komatsu S， et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer. 2012， 106(4)：740-747., http://www.100md.com(覃新干)